5/31
02:00 am
irmd
IRadimed Co. (
NASDAQ: IRMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.
Low
Report
IRadimed Co. (
NASDAQ: IRMD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.